CellWell record HH-398098
Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis
Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
PLoS medicine ยท 2023
In plain language
Current or recent use of progestagen-only contraceptives was associated with a slight increase in breast cancer risk in premenopausal women, similar in size to combined hormonal contraceptives.
- Evidence
- Established
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-398098
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.